Data / Form D filings / Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd.: Form D filings
Scinai Immunotherapeutics Ltd., a pharmaceuticals company in Jerusalem, Israel, filed 2 Form D notices with the SEC between 2023 and 2024. The latest, on January 12, 2024, reports $1.7 million sold of a $1.7 million offering to 4 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- JERUSALEM BIOPARK, 2ND FLOOR,, HADASSAH EIN KEREM CAMPUS, Jerusalem, Israel, 91120
- Phone
- 972-8-9302529
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Israel
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1611747
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 12, 2024 | New notice | $1,694,259 | $1,694,259 | 4 | Dec 29, 2023 | sec.gov | |
| Oct 3, 2023 | New notice | $1,329,254 | $1,329,254 | 1 | Sep 19, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Yael Margolin | Director | |
| Elad Mark | Executive Officer | |
| Morris Laster | Director | |
| Amir Reichman | Executive Officer, Director | |
| Tamar Ben-Yedidia | Executive Officer | |
| Adi Raviv | Director | |
| Samuel Moed | Director | |
| Mark Germain | Director | |
| Jay Green | Director | |
| Avner Rotman | Executive Officer, Director | |
| Uri Ben Or | Executive Officer |
Every Form D from the week of Jan 8, 2024 · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Scinai Immunotherapeutics Ltd. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.